Price$67.38-1.06 (-1.55%)
03:15 PM04:15 PM
News · 26 weeks13+50%
2025-10-262026-04-19
Mix890d
- SEC Filings4(50%)
- Market3(38%)
- Other1(13%)
Latest news
25 items- SECUtah Medical Products Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - UTAH MEDICAL PRODUCTS INC (0000706698) (Filer)
- NEWSUtah Medical Products, Inc. Reports Financial Performance for First Quarter 2026SALT LAKE CITY, UT / ACCESS Newswire / April 23, 2026 / In the first calendar quarter (1Q) of 2026, Utah Medical Products, Inc. (NASDAQ:UTMD) attained financial results which were consistent with its previously announced projections for calendar year 2026. But because of the relatively short span of time, results for any given three-month period in comparison with a previous three-month period may not be indicative of comparative results for the year as a whole.Summary of results.The following is a summary comparison of 1Q 2026 with 1Q 2025 income statement measures:Revenues (Sales):(10.2%)Gross Profit (GP):( 4.6%)Operating Income (OI):(18.7%)Net Income (NI):(14.4%)Earnings Per Share (EPS):(
- SECSEC Form DEF 14A filed by Utah Medical Products Inc.DEF 14A - UTAH MEDICAL PRODUCTS INC (0000706698) (Filer)
- SECSEC Form 10-K filed by Utah Medical Products Inc.10-K - UTAH MEDICAL PRODUCTS INC (0000706698) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Utah Medical Products Inc.SCHEDULE 13G/A - UTAH MEDICAL PRODUCTS INC (0000706698) (Subject)
- NEWSUtah Medical Products, Inc. Announces Quarterly DividendSALT LAKE CITY, UT / ACCESS Newswire / February 4, 2026 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty-one cents ($.31) per share of common stock payable on April 3, 2026 to stockholders of record at the close of business on March 17, 2026. This is a 1.6% increase over the dividend declared in the same quarter of the prior year.Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for o
- SECUtah Medical Products Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - UTAH MEDICAL PRODUCTS INC (0000706698) (Filer)
- NEWSUTMD Reports Year 2025 and Fourth Quarter Financial PerformanceSALT LAKE CITY, UT / ACCESS Newswire / January 29, 2026 / With some unexpected circumstances in 2025, Utah Medical Products, Inc (UTMD) did not achieve its beginning of year financial projections. Nevertheless the Company retained excellent profit margins, and increased its year-ending cash balances to $85.8 million despite paying $4.0 million in dividends to stockholders and repurchasing 4.5% (since the end of 2024) of its shares in the open market for $8.4 million.Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia Dollars; £ or GBP = UK Pound Sterling; C$ or CAD = Canadian Dollars; and € or EUR = Euros. Currency amounts throughout this report are in thousand
- INSIDERSEC Form 3 filed by new insider Timken Kevin3 - UTAH MEDICAL PRODUCTS INC (0000706698) (Issuer)
- INSIDERSEC Form 4 filed by Principal Financial Officer Koopman Brian4 - UTAH MEDICAL PRODUCTS INC (0000706698) (Issuer)
- SECSEC Form 10-Q filed by Utah Medical Products Inc.10-Q - UTAH MEDICAL PRODUCTS INC (0000706698) (Filer)
- SECUtah Medical Products Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits8-K - UTAH MEDICAL PRODUCTS INC (0000706698) (Filer)
- NEWSUtah Medical Products, Inc. Appoints Director and Increases Quarterly DividendSALT LAKE CITY, UT / ACCESS Newswire / November 4, 2025 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors has appointed Kevin C. Timken, Esq to its Board of Directors. Mr. Timken, who served as UTMD's outside legal counsel for over twenty years prior to his retirement in 2025, graduated with a J.D. degree from the University of Utah College of Law in 1997. The Board believes his robust understanding of the functional and strategic challenges that the Company faces will be integral for continuing UTMD's future excellent performance.In addition, the Board of Directors approved a quarterly cash dividend of thirty-one cents ($.31) per share of common stock payable
- SECUtah Medical Products Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - UTAH MEDICAL PRODUCTS INC (0000706698) (Filer)
- NEWSUTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2025SALT LAKE CITY, UT / ACCESS Newswire / October 23, 2025 / Utah Medical Products, Inc. (NASDAQ:UTMD) reports third quarter (3Q) and first nine months (9M) of calendar year 2025 financial results that were unusually hampered by global trade uncertainty.Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia Dollars; £ or GBP = UK Pound Sterling; C$ or CAD = Canadian Dollars; and € or EUR = Euros. Currency amounts throughout this report are in thousands, except per share amounts and where noted.Overview of ResultsThe following is a summary comparison of 3Q and 9M of calendar 2025 with 3Q and 9M 2024 income statement measures: 3Q 9M 2025 to 2024 Comparison (July-S
- INSIDERPrincipal Financial Officer Koopman Brian gifted 50 shares, decreasing direct ownership by 6% to 832 units (SEC Form 4)4 - UTAH MEDICAL PRODUCTS INC (0000706698) (Issuer)
- INSIDERDirector Richins Paul O gifted 100 shares (SEC Form 4)4 - UTAH MEDICAL PRODUCTS INC (0000706698) (Issuer)
- SECSEC Form 10-Q filed by Utah Medical Products Inc.10-Q - UTAH MEDICAL PRODUCTS INC (0000706698) (Filer)
- NEWSUtah Medical Products, Inc. Announces Quarterly DividendSALT LAKE CITY, UT / ACCESS Newswire / July 29, 2025 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty and one-half cents ($.305) per share of common stock payable on October 2, 2025 to stockholders of record at the close of business on September 17, 2025. This is a 1.7% increase over the dividend declared in the same quarter of the prior year.Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the s
- SECUtah Medical Products Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - UTAH MEDICAL PRODUCTS INC (0000706698) (Filer)
- NEWSUTMD Reports Financial Performance for Second Calendar Quarter and First Half 2025SALT LAKE CITY, UT / ACCESS Newswire / July 24, 2025 / Utah Medical Products, Inc. (NASDAQ:UTMD) reports second calendar quarter (2Q) and first half (1H) 2025 financial results which are consistent with overall beginning-of-year projections.Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia Dollars; £ or GBP = UK Pound Sterling; C$ or CAD = Canadian Dollars; and € or EUR = Euros. Currency amounts throughout this report are in thousands, except per share amounts and where noted. Because of the relatively short span of time, results for any given three-month period in comparison with a previous three-month period may not be indicative of comparative results for
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Utah Medical Products Inc.SCHEDULE 13G/A - UTAH MEDICAL PRODUCTS INC (0000706698) (Subject)
- SECSEC Form SD filed by Utah Medical Products Inc.SD - UTAH MEDICAL PRODUCTS INC (0000706698) (Filer)
- SECSEC Form 10-Q filed by Utah Medical Products Inc.10-Q - UTAH MEDICAL PRODUCTS INC (0000706698) (Filer)
- NEWSUtah Medical Products, Inc. Announces Quarterly DividendSALT LAKE CITY, UT / ACCESS Newswire / May 6, 2025 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty and one-half cents ($.305) per share of common stock payable on July 3, 2025 to stockholders of record at the close of business on June 16, 2025. This is a 1.7% increase over the dividend declared in the same quarter of the prior year.Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard fo